MedPage Today brought together three expert leaders for a virtual roundtable discussion on the joint meeting of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and ...

Researchers are continuing to explore how the CXCL13-to-BAFF ratio can be used to advance precision medicine for people with multiple sclerosis.

A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease ...

A long-term study has identified a potential biomarker that could help detect which patients are progressing toward more severe forms of multiple sclerosis.

Recent research on fluid biomarkers in multiple sclerosis (MS) frames an emerging picture of two aspects of the disease: inflammatory activity measured with neurofilament light chain (NfL), and ...

Multiple sclerosis (MS) is a chronic autoimmune condition affecting the CNS. Despite recent refinements in diagnostic criteria and the availability of ancillary studies, such as cerebrospinal fluid ...

To diagnose multiple sclerosis (MS), the central vein sign (CVS) on brain MRI appears to work as well as oligoclonal bands (OCBs) in cerebrospinal fluid (CSF), and combining the two biomarkers yields ...

The body's immune response to Epstein-Barr virus (EBV) may play a role in causing damage in people with multiple sclerosis, according to a new study led by UTHealth Houston. EBV infection has long ...

Multiple sclerosis occurs when a person’s immune system is triggered to attack the myelin sheath—a protective coating surrounding nerve cells in the central nervous system (CNS). The CNS is made up of ...